Roche, Cipla launch ‘Antibody Cocktail’ for treatment of mild to moderate COVID-19

Priced at Rs 59,750 per dose, the medicine consists of an amalgamation of Casirivimab and Imdevimab drugs. Cipla will take care of the distribution of the product.

source https://zeenews.india.com/india/roche-cipla-launch-antibody-cocktail-for-treatment-of-mild-to-moderate-covid-19-2364018.html